Cargando…
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
Myostatin is a negative regulator of skeletal muscle growth secreted by skeletal myocytes. In the past years, myostatin inhibition sparked interest among the scientific community for its potential to enhance muscle growth and to reduce, or even prevent, muscle atrophy. These characteristics make it...
Autores principales: | Abati, Elena, Manini, Arianna, Comi, Giacomo Pietro, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213329/ https://www.ncbi.nlm.nih.gov/pubmed/35727341 http://dx.doi.org/10.1007/s00018-022-04408-w |
Ejemplares similares
-
Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
por: Manini, Arianna, et al.
Publicado: (2022) -
Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies
por: Abati, Elena, et al.
Publicado: (2021) -
Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy
por: Ramirez, Agnese, et al.
Publicado: (2018) -
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
por: Costamagna, Gianluca, et al.
Publicado: (2020) -
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD)
por: Harish, Pradeep, et al.
Publicado: (2019)